| 000 | 01614 a2200445 4500 | ||
|---|---|---|---|
| 005 | 20250513110913.0 | ||
| 264 | 0 | _c19970204 | |
| 008 | 199702s 0 0 eng d | ||
| 022 | _a0344-5704 | ||
| 024 | 7 |
_a10.1007/s002800050537 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEgorin, M J | |
| 245 | 0 | 0 |
_aPlasma pharmacokinetics, bioavailability, and tissue distribution in CD2F1 mice of halomon, an antitumor halogenated monoterpene isolated from the red algae Portieria hornemannii. _h[electronic resource] |
| 260 |
_bCancer chemotherapy and pharmacology _c1996 |
||
| 300 |
_a51-60 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aArea Under Curve |
| 650 | 0 | 4 | _aBiological Availability |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHydrocarbons, Halogenated _xadministration & dosage |
| 650 | 0 | 4 | _aInjections, Intraperitoneal |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 | _aInjections, Subcutaneous |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMetabolic Clearance Rate |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aRhodophyta |
| 650 | 0 | 4 | _aTissue Distribution |
| 700 | 1 | _aSentz, D L | |
| 700 | 1 | _aRosen, D M | |
| 700 | 1 | _aBallesteros, M F | |
| 700 | 1 | _aKearns, C M | |
| 700 | 1 | _aCallery, P S | |
| 700 | 1 | _aEiseman, J L | |
| 773 | 0 |
_tCancer chemotherapy and pharmacology _gvol. 39 _gno. 1-2 _gp. 51-60 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s002800050537 _zAvailable from publisher's website |
| 999 |
_c8986703 _d8986703 |
||